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ABSTRACT
WRAPS – A SYSTEM FOR DETERMINING THE PROBABILITY OF
PROKARYOTIC PROTEIN ANNOTATION CORRECTNESS

Benjamin K. Nelson, MS

University of Nebraska, 2012

Advisor: Dhundy Bastola, Ph.D

Advances in sequencing technology have resulted in the sequencing of whole
genomes from many simple organisms such as fungi and bacteria, while allowing the
assembly of much more complex genomes like humans and chimpanzees. Consequently,
association of segments of newly sequenced genomes to specific function (i.e.
annotation) is being completed by comparative study of protein coding regions from
previously annotated genome data. While this is an ideal procedure to process and
annotate huge number of available genomic sequences, this approach can potentially lead
to propagating erroneous annotation in a public sequence repository and vastly diminish
the integrity of these new annotation of genome sequences. In this project, the WRongly
Annotated Protein identification System (WRAPS) has been created to analyze
previously annotated proteins quickly and efficiently. The likeliness that the protein is
correctly annotated is determined by weighted scoring schema based on conservation of
`

protein domain, the domains present in different reading frames, and isoelectric point. A
study of 88,023 proteins of Yersinia, Staphylococcus, and Bacillus using WRAPS show
that there are several proteins that can be considered wrongly annotated, as well as the
correctness of annotation among these proteins.
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INTRODUCTION
In science, the scientific method is used to solve problems. This method enables a
scientist to test a property within the natural world. To do this, information is needed to
first define a hypothesis and to test that hypothesis itself. In the fields of proteomics and
genomics, this method holds true as well. In these sciences, one of the most common
information are sequences, both DNA and protein. Since the discovery of DNA, many
methods have been developed to sequence DNA and proteins for different organisms.
Over time, these methods have become quicker and cheaper leading to an exponential
increase in the number of sequences available. One of the leading databases, GenBank,
showed an exponential rise in sequences being added to it, now doubling in size every 18
months, as seen in Figure 1 [1].
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Figure 1: Increase in the number of sequences added to GenBank
While DNA and protein sequences are useful by themselves, often times an
adjoining annotation is needed. An annotation tells useful things about the sequence. A
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DNA sequence annotation may have information about coding sequences, the protein
product of these coding sequences, and the protein translation of these coding sequences
[2]. A protein sequence may have information about particular domains and molecules
that bind to the protein. To discover the annotations, the traditional method is to
experiment with these proteins within a biological lab [2]. While this method is very
thorough, it is very slow. With the exponential increase in the number of sequencing
projects, annotating these sequences using the traditional method is falling more and
more behind.
To solve this problem automated methods were used to keep up with the
increasing wave of sequence data being introduced. Systems such as GLIMMER and
GeneMark help fill in the annotations for the abundance of sequences [3]. These methods
create new annotations by comparing genes from the sequences to similar previously
annotated genes already available in the database. This method is very fast and effective
in annotating new sequences. However, it has been continuously introducing error to
databases. If a gene is incorrectly annotated, then subsequent similar genes will also be
incorrectly annotated. As incorrectly annotated genes are used in the annotation process,
the error propagates. In fact, the percent of misannotated sequences of new sequences
submitted to public databases has been rising [4]. This causes a problem with research as
annotations of proteins must be validated as to avoid erroneous results.
To help reverse this problem by identifying the incorrect annotation, the Wrongly
Annotated Protein Identification System (WRAPS) has been created. This system tests
each protein on six different qualities that would be found in most proteins. Each of
these evidence tests are weighted for each genus. The resulting weights are used to score
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individual proteins. A protein's score will range from zero to one, giving the probability
that a protein is correctly annotated. By using these scores, proteins may be flagged as
incorrectly annotated so that flagged proteins may receive more stringent review and
possibly be removed from the pool of possible proteins to be used in homology searches.
Once the incorrectly annotated proteins are identified, the contents of public databases
can be improved.
WRAPS has been created with certain goals in mind. First and foremost, this
system is to provide an accurate measure into the correctness of a protein. Next, this
system should be fast, as to avoid some of the pitfalls of its predecessor, GARBASE [5].
Next, this is to take advantage of biological properties of proteins and their corresponding
nucleotides. Today, there are methods to identify wrongly annotated genomes. However,
most are concerned only with computational aspects surrounding the methods used to
annotate them [5, 6, 7]. While this may work better in a pipeline, these methods use the
same set of tools resulting in the incorrect annotation in the first place. By using
biological properties of proteins, this allows for new models to be made to further enrich
protein annotation. Next, this system should be able to process information quickly, as
annotation quality control means nothing if it falls victim to the flaws of traditional
annotation in a wet lab. This is accomplished by parallelizing the evidence tests upon
individual proteins. This greatly improves the amount of time it takes for WRAPS to run.
This is because of the numbers of protein sequences to be tested within the database,
which range from 50,000 to 300,000 in different jobs. Finally, this system should be able
to be portable across many machines, provided that you have access to a MySQL
database. This is accomplished by storing configurations in a file and accepting
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configurations as command line arguments, so that the programs themselves do not have
to be changed when using different computers.

BACKGROUND
DNA
Deoxyribonucleic acid, or better known as DNA, is the basic cellular information
for living cells. DNA is comprised of two strands [9]. Each of these strands is a polymer,
meaning it is a chain of repeated molecules. This polymer is structured as a series of
nitrogenous bases attached to a sugar backbone. While the sugar backbone is a
constantly repeated pattern, the bases vary. In fact, there are four different nitrogenous
bases, namely adenine (A), cytosine (C), guanine (G), and thymine (T) [9]. Together,
these bases are called nucleotides. By varying the sequence of these nucleotides, the
DNA codes for different cellular products. Between the two strands, each of the
nucleotides in one strand is matched up with the complement base in the opposite strand.
For instance, the A nucleotide will match to the T nucleotide in the opposite strand and
the C nucleotide will match to the G nucleotide in the opposite strand. The opposite of
these pairings are also true between the two DNA strands. While both strands are
comprised of the same molecules, they are oriented in opposite directions. One strand is
called the 5’ to 3’ strand, while the other is called the 3’ to 5’ strand. This is because of
the structure of the sugar backbone in DNA. The sugar takes the form of a ring, and each
of the carbon atoms can be numbered from one to five. On the five carbon, there is a
phosphate group that is attached to it. This phosphate is also attached to a three carbon
on the next phosphate group. Depending on the way that this is read (from left to right),
`
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the five carbon will be bonded to the phosphate, which is then bonded to the three carbon
for a “5 to 3” strand, or the opposite direction for the “3 to 5 strand”. The chemical
structure of a DNA strand can be seen in Figure 2. When studying DNA within
bioinformatics, DNA is represented by a letter string of A, C, G, and T to designate the
order of these nitrogenous bases in the 5' to 3' direction. It is not necessary to have the
sequence of the 3 to 5 strand, as this can be derived by taking the complement of the 5 to
3 strand and reversing it.

Figure 2: Chemical structure of DNA [36]

Within a DNA sequence, there are important subsequences within it are called
genes. Genes code for proteins. Proteins are polymers of discrete subunits called amino
acids. Much like DNA, proteins are different, based on the amino acids used in the
sequence. To be able to utilize the information within DNA, another molecule is made
called ribonucleic acid (RNA) [10]. This serves as an intermediate to be taken to the
ribosomes, which are proteins which facilitate the translation of DNA. RNA is much like
DNA, only with a few differences. The first major difference is that RNA is only single
`

6
stranded, unlike DNA, which is double stranded. The second major difference is RNA
has the uracil (U) nucleotide instead of the T nucleotide. The third major difference is
RNA uses a different sugar molecule to use as the background.

PROTEIN
With each amino acid in a protein sequence, it has a corresponding sequence of
three contiguous nucleotides. Each of these 3-mers is called a codon. Each of these 64
possible codons code for an amino acid [10,11,12]. Within humans, most bacteria, and
many other organisms there are 20 different amino acids to be coded for [11,12]. Since
not all of the possible codons can code for a unique amino acid, this means that most
amino acids are coded for by multiple codons. For most amino acids, there are on
average three different codons that can code for it. However, there are two amino acids,
methionine and tryptophan, that have only one way of being coded. There are also three
special codons called “stop” codons which terminate translation of the protein.
In a DNA sequence, a gene works only when the codons are in the correct frame.
The frame of a DNA sequence defines which nucleotide 3-mers together form a codon.
There are six different frames for a nucleotide, being 0, -0, 1, -1, 2, and -2. For instance,
in the 0 frame, the codons begins with the first nucleotide in the sequence. In the 1
frame, the codons begin with the second nucleotide in the sequence. In the 2 frame, the
codons begin with the third nucleotide in the sequence. In the negative frames, instead of
dealing with the normal 5' to 3' strand, the complement 3' to 5' strand is used. When a
different frame is used, called a frameshift, this can radically affect the outcome of the
amino acids within the created protein, which can cause a non-functional protein. An
example of all six frameshifts can be found below in Table 1. In this figure, adjoining
`
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codons are spaced to differentiate the codons.

Table 1: Demonstration of all six frameshifts of a nucleotide sequence
Frame

Nucleotide Sequence

Translation

1

GCCTATGC

AY

2

CCTATGC

PM

3

CTATGC

LC

-1

GCATAGGC

A(STOP)

-2

CATAGGC

HR

-3

ATAGGC

IG

Within an organism, codons coding for the same amino acid will not always be
used equally. In fact, in many organisms, some specific codons will be preferred over
others when coding for a single amino acid. This is called codon bias. Codon bias
happens due to transfer RNA (tRNA). This molecule helps construct the protein by
adding an amino acid to the protein chain being assembled. There are 64 different
tRNA's possible, each with the complementary sequence for a given codon. In a cell, it is
more efficient to prefer one codon over another if they code for the same amino acid
because it means that one tRNA can be produced more than others [12].
The proteins that are coded by genes are needed in performing activities within
the cell. One such example is an enzyme. An enzyme has an active site that is specific to
a molecule. Once the specific molecule is attached, an action is performed. For instance,
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a molecule could have an active group cleaved. Another function a protein can provide is
structure. For example, this could be hair, fur, or chitin. Proteins for a particular
organism are most often not unique to that organism. In fact, across many species, a
particular protein could exist. This is called conservation. Conservation does not only
apply to entire proteins; it may also apply to amino acids within a protein, genes or even
subsequences of the genome of an organism. A conserved protein or sequence means this
is very beneficial to the organism's survival or perhaps even lethal in its absence. Within
a genome, a special class of conservation exists. This is called synteny. Synteny is the
conservation of gene order [35]. The order conserved can be forward or backwards,
provided that the order is maintained. All possible ways that synteny can exist is shown
below in Figure 3.

Protein set 1

Protein p

Protein i

Protein q

Protein set 2

Protein m

Protein k

Protein n

Protein set 3

Protein y

Protein i

Protein x

Protein set 4

Protein w

Protein v

Protein t

Figure 3: Demonstration of synteny. Protein sets 1, 2 and 3 exhibit synteny while protein
set 4 does not exhibit synteny with any other protein set
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Within a protein, there are four different types of structure. The first is primary
structure. This is only the sequence of amino acids of the protein. The secondary
structure is the structures that the amino acids as a result of being connected to each
other. There are two main secondary structures. They are alpha helix and beta sheet. As
the names suggest, the alpha helix is a helical structure and the beta sheet is a flat sheet of
amino acids. The tertiary structure is a three dimensional structure of the protein. This is
due to event such as the protein burying its hydrophobic residues within itself or the
cysteine amino acid forming a disulfide bond with another cysteine. Finally, the
quaternary structure is how the subunits of the protein, called domains, fit together.
Domains are a structure that is often repeated within multiple proteins that most often
have a function associated with them, such as ion channels and active sites [13].
Domains are an important part of discovering what a protein does. In fact, protein
function can usually be summarized by the domain(s) that the protein contains. Most
often, these domains are conserved amongst homologous proteins. The function of a
domain within a protein is crucial for the protein to be of use within the cell. Currently,
there is a database called the Conserved Domain Database (CDD) that contains well
studied domains [13]. If a domain is found within the CDD, it will have annotations
explaining exactly what that domain is responsible for within a protein.
While domains are important within a protein, the individual amino acids carry a
certain weight towards its characteristics. One example of this is the charges provided by
individual amino acids. These are either positively charged or negatively charged. These
contribute to the total electric charge of the protein. When a protein is in a solution, the
charge is affected by the pH of the solution. The point in which the charge of the protein
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is neutral is called the isoelectric point. This property is important because proteins with
certain isoelectric points will be localized to certain areas within the cell [14]. This idea
can be expanded to protein function. Proteins with similar function will be localized to a
similar location. Because of this, the proteins will have a similar isoelectric point.
Inversely, if two proteins have the same isoelectric point, they may be located in the cell
in similar locations.

ALIGNMENTS
In bioinformatics, sequences can be compared to each other using an alignment.
An alignment is a way to compare protein or DNA sequences. An alignment is
accomplished by laying two or more sequences side by side so that the best match
between them is accomplished. By adding gaps and shifting parts of the sequences, a
“best fit” is reached called the optimal alignment. An alignment enables the
bioinformatist to show structural or functional similarities between the sequences [15].
There are two main ways of aligning sequences, which are global and local alignments.
By using a global alignment, the two sequences are compared as a whole [16]. To create
the optimal alignment, gaps are introduced into either sequence. A good example of a
global alignment algorithm is the Needleman-Wunsch algorithm[16].
A local alignment differs from a global alignment by focusing on subsequences
within the sequences being aligned that are identical or very similar [17]. It is from these
subsequences that match that the alignment is built around. From here, gaps are
introduced into both sequences to allow an optimal alignment. A good example of a local
alignment algorithm is the Smith-Waterman algorithm [37]. It is actually from this local
algorithm that the famous BLAST algorithm [17] is based.
`
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BLAST is most likely one of the most influential algorithms within
bioinformatics. BLAST was developed by National Center for Biotechnology
Information (NCBI) as a way to find sequences that align closely with a query sequence
[17]. BLAST can be used with both nucleotide and protein sequences. This is done by
dividing the query sequence into words of a certain length (k-mers). For DNA sequences,
this length is usually 11 nucleotides. Regions within sequences that are repetitions of the
same elements are ignored. From here, the database of sequences to be searched is
examined for these same words. Once a sequence with an identical word is found, this
word is extended in both sequences, at both sides of each subsequence. These words are
extended as long as the aligned words are above a certain predefined cutoff score. From
here, these matching words or high-scoring pairs, as the BLAST documentation call
them, from the same sequence are combined to create alignments. For each alignment
created, a number called the E value is given. The E value [38] is a measure of how close
the aligned sequences are, by showing the number of times an unrelated sequence in the
database would be aligned in this way by chance. The lower E value is for the hit
sequence, the better the alignment will be between the two sequences.
BLAST itself is actually just the basic algorithm in a series of programs provided
by NCBI. Amongst them are BLASTN and BLASTP which work with nucleotides and
proteins respectively. There are also related programs such as PSI-BLAST and RPSBLAST. In the case of PSI-BLAST, this uses the results of a BLASTP search against a
database to create a matrix that shows the conservation between the alignments [18].
This can find divergent evolutionary relationships. In the case of RPS-BLAST, a number
of matrices like those generated in a PSI-BLAST, are queried against a reference
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sequence [19]. This allows the user to find conserved evolutionary motifs within the
sequence, such as domains.

AUTOMATED ANNOTATION METHODS
In the world today, there are many different pipelines that are used in the
automatic annotation of putative proteins from prokaryotic organisms [7, 20]. Despite
the differences in algorithms, these pipelines there are two major steps involved in
protein annotation.
The first step in the annotation process is gene finding, or structural annotation [7,
20]. Most gene finding algorithms make use of Markov models to help predict genes. A
Markov model is a series of states, with the first n states determining the probability of
the next given state. For a Markov model of n order, the previous n states in the sequence
are used to predict the next state. Within a DNA sequence, each of the nucleotides is a
state. An example could be a 5th order Markov model with the current sequence of
nucleotides being ATGTA. The probability that the the next nucleotide will be a A or a G
is most likely going to be much lower than the probability that the next nucleotide will be
a C or a T. To use a Markov model, it must be trained by using a set of data in which it
can discover the probability of each base after every possible set of n bases. For the
Markov model to work, it needs to have 4n+1 probabilities calculated. As the order gets
higher, this is much more demanding, as each of the sets of n +1 bases are required. Due
to this problem, one gene finder has dominated the field. This gene finder is GLIMMER
[7]. GLIMMER uses an Interpolated Markov model (IMM), rather than a normal
Markov model. IMMs hold an advantage over normal Markov models due to the number
of states required to be calculated a given probability of the next state. For instance, if
`
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the current sequence contains AGT, and the probability calculated from a 3rd order model
that the next state will be G is the same probability as if the current sequence contains GT
as a 2nd order model, there is no benefit to training the model to the 3rd order over the 2nd.
This enables GLIMMER to only have to use larger order models on individual rare cases
[20].
The second step in the annotation process is functional annotation [7,21]. Several
tools are available here to find an annotation previously defined that fits the unannotated
protein like BLAST, BLAST Extended Repraze (BER), InterPro, and hidden Markov
models. Of these methods, the simplest is BLAST. In this context, a simple BLASTX
search from the putative gene's nucleotide sequence or a BLASTP search from the
putative gene's protein sequence against a protein database would potentially find
homologous proteins and therefore give a functional annotation for the putative gene in
question. The next method, BER helps correct some of the errors within the putative
gene, such as frameshift mutations and premature stop codons as well as extending the
nucleotide sequence by adding additional bases on both of the upstream and downstream
ends of the gene [7]. This can be especially helpful in cases where the organism in which
you sequenced the DNA expressed a rare phenotype caused by a mutation like this. To
use a HMM to find functional annotations, first HMMs are trained from known members
that share a specific function. Next the putative gene is scored from the HMM. If this
gene score highly enough within the HMM, it can be considered a member of the family.
The next tool that can be used to discover functional annotation is a database such as
InterPro. These databases house multiple sequence alignments on a single feature [22].
This feature may be a domain, site, or a shared functional family.
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Each of these steps is critical in the current execution of an automatic annotation
pipeline. Currently there are many different automated annotation pipelines in
production. Among them are the IGS annotation engine [7] and the J. Craig Venter
Institute (JCVI) annotation service [6]. To predict a correct protein annotation using the
IGS pipeline, GLIMMER and RNA prediction are used to find the structural annotations
while BLAST variants, BER, and HMMs are used to find functional annotations. The
data gathered in each step is then used to determine whether the protein is hypothetical or
has enough supporting data to be considered a true protein. When the JCVI pipeline is
used to predict protein annotations, GLIMMER identifies putative genes within a
genomic sequence that are thought to encode proteins. Next, BLAST, BER, HMMs are
used to compare these with existing families of proteins. If a putative protein fits a
family profile, it is considered to be part of the family.

PUBLIC DATABASES
Conserved Domain Database
The Conserved Domain Database (CDD), as the name suggests, is a database
containing domains conserved and repeated across many different proteins. This
database has been collected and manually curated by the National Center for
Biotechnology Information (NCBI) to ensure complete accuracy [13]. Using Entrez, this
database is linked to other NCBI databases. These domains are three dimensional
structures within proteins that can help determine the protein’s function within the cell.
The CDD first began as a mirror of other popular domain databases, such as Pfam. Pfam
is a domain databases that contain profile Hidden Markov Models for different domain
families built from multiple sequence alignments [23]. The CDD has since differentiated
`
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itself from databases like Pfam by using domain hierarchies. For instance, a protein may
match many domain Hidden Markov Models from Pfam, but only a small number of
domain Hidden Markov Models from CDD [13]. This is because the profile Hidden
Markov Models in Pfam can be based on sequences aligned on many properties. For
instance, this could be a common structural domain between proteins that have very
different functions. To avoid this pitfall, the CDD uses a hierarchical grouping of protein
domains. The protein in question is compared to a tree of domain profile Hidden Markov
Models, so that the search starts out broad, but ends up on a specific set of domains. The
CDD is available for download onto local systems via an FTP site. The database can be
created on a local machine by using the “formatrpsdb” command within the NCBI
Software Development Toolkit.

GenBank
GenBank is a public database curated by NCBI [24]. This database holds protein
and DNA sequences submitted by both large and small laboratories, as well as their
annotations. Sequence can be obtained as proteins, nucleotides, or even whole genomes.
GenBank is accessible by the Entrez, which allows users to search for sequences as well
as do BLAST searches. All of the data that is available online is also available to be
downloaded locally via an FTP site. The files within GenBank are in GenBank format, as
seen in Appendix A. Files in GenBank format contain biological annotations as well as
bibliographical annotations surrounding the sequence(s) in question. As of February
2012, there were 1,498,192,468 total sequences in GenBank [1].
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PROGRAMMING LANGUAGES
Perl
Perl is an interpreted programming language developed by Larry Wall in the late
1980's [25]. The original purpose of this programming language was to process reports,
making this language efficient at processing text. Perl became popular language to use
due to its ease of use, partially due to the lack of type checking used in other scripting
languages [26]. By having most all primitive data types interchangeable as a single type,
the scalar, this saves developer’s time. In the bioinformatics realm, this programming
language has widespread use, most likely due to the ease of learning, the available code
modules on the Internet, and most importantly, the ability to easily deal with text
documents. The ability to deal with text is especially important within bioinformatics
because this is the format of most all publicly available data.

BioPerl
While Perl is very helpful within bioinformatics, this results in many different
users doing the same thing, while all writing different code to do this. To solve this
problem, a collection of Perl modules called BioPerl have been created to help within the
bioinformatics domain [27]. To accomplish this, BioPerl uses an object oriented
approach. For example, in the SeqIO module, an annotated sequence can be read from a
file into an object in memory. From memory, methods can be called to view the
properties of a sequence. BioPerl solves many bioinformatics problems, such as parsing
files, indexing databases, and using other bioinformatics tools like BLAST. By having
modules such as BioPerl, this saves developers a great deal of time, as code does not need

`

17
to be written a second time.

MySQL
MySQL is an open source relational database management system [34]. It uses
the SQL query language to perform database transactions.

METHODS
Overview
The main goal of WRAPS is to input annotated proteins specified by the user and
to output a score that indicates how likely the protein for which it codes is properly
annotated. To accomplish this goal, this system is divided into four discrete sections. A
simplified outline of this system can be found in Figure 4. A more in-depth diagram of
this system can be found in Appendix B, as well as diagrams for each of the scripts that
help set up and execute WRAPS.

`
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Create Database

Populate Database

Run Evidence Tests on each Protein

Find weights of each Genus Group

Score Proteins

Figure 4: Structure of WRAPS

The first step in WRAPS is database population. This step involves placing
information for each protein sequence into several tables within the MySQL database.
An entity relationship diagram for the database can be found in Appendix C. To
accomplish this, two Perl scripts are organized in a master-slave format, so that database
population can be easily parallelized. The first script handles user input. The user inputs
database credentials, the name of the database to be populated, and the directories in
which the sequence data, in GenBank format [39], is located. An example of a file in the
GenBank format can be found in Appendix D. This script recursively descends into the
directories to find all possible files that have valid GenBank extensions (.seq, .gbk). It
`
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then reads a configuration file to find the host location and the maximum number of
allowed child processes to use. For each file in the input directories, a child process is
spawned which runs a second script through use of the fork system call. The second
script uses BioPerl to parse the GenBank file and extract data pertaining to each coding
sequence within the genome. This extracted data is inserted into the specified MySQL
database. Once the maximum number of slave processes has been created, the master
process waits until one of the slave processes has died. Once a slave has died, the master
will create another slave process to run the second script upon the next file. This process
continues until all of the valid GenBank files have been processed by the second script.
The second section of WRAPS tests each protein upon the evidence criteria. This
step involves reading information from the MySQL database protein entries, performing
tests upon the data, and inserting a value indicating the outcome of each evidence test on
each protein. This is implemented in a series of Perl scripts. This section is also
structured in a master-slave format. The first Perl script, the launcher, reads user
information, being the database credentials and the database to be used. When the
launcher script runs, it reads from the WRAPS configuration file the number of slave
processes to use and the number of proteins that have been populated within the selected
database. For each protein, the launcher executes a fork system call and executes an
instance of a second Perl script, the evidence caller. A number of slave processes are
created by the launcher and limited to the maximum number of slave processes specified
in the configuration file. When a slave process dies, a new slave process is spawned to
run the evidence caller script upon the next protein until all of the proteins have been run
with the evidence caller script. Within the evidence caller script, a series of scripts from a
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designated directory is called on the specific protein in question. Each of the called
scripts atomically runs a single evidence test upon the protein and returns “PASS” if the
protein passed the evidence test and “FAIL” if the protein failed the evidence test. The
individual evidence tests will be discussed more thoroughly later in this paper. After each
evidence test is completed, the result, a MySQL script is created to record the outcome of
the evidence test upon the protein the script was run. This is not immediately inserted in
database as any evidence test results do not affect any other evidence test results, so the
results of each evidence test can be recorded into the database after the completion of all
evidence tests upon each protein. By using this practice, the I/O load on the disk is
considerably lessened, which allows the parallel evidence testing processes to analyze
proteins faster.
For third section of WRAPS the evidence weights associated with each family of
related sequence are calculated. This is done by a Perl script. Each group of related
sequences is grouped by genus. For instance, Yersinia pestis and Yersinia
pseudotuberculosis will both be grouped in the Yersinia family. Using the number of
proteins that have passed the evidence tests within the positive control the weights will be
calculated. The actual equation used to calculate the weights will be discussed later in
this paper.
In final section of WRAPS, the scores for each protein are calculated. This is
done by a pair of Perl scripts. This section is structured in a master-slave format, with the
first Perl script using the fork system call to assign a unique protein to the second Perl
script within each slave process. The method used to calculate the score will be
discussed later in this paper. After WRAPS has been run, the resulting scores for each
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protein can be found in the MySQL database.

Parallelization
To parallelize WRAPS, a simple method involving the "fork" system call was
used. By running the WRAPS launcher script a pool of child processes are spawned in
which each child process handles the evidence test evaluations for a single protein. This
enables WRAPS to run much faster than only evaluating evidence tests in series. Since
the output of one evidence test affects no other concurrently running evidence tests, this
effectively compartmentalizes individual proteins. This is advantageous as the failure of
the evaluation of the evidence tests on a single protein does not affect the evaluation of
the evidence tests upon any other protein. Due to the atomic nature of the evidences tests
used upon each protein, this allows for very simple implementation. In the launcher
script, the parent process keeps spawning child processes to evaluate proteins. The parent
will keep track of the number of children it has while only spawning up to a user defined
limit. Once that limit is reached, the parent will wait until a child has died, and then
spawn the next process. This process is repeated until there are no additional proteins to
be tested. After this, the parent waits for its child processes to die before terminating as
to avoid "zombie" processes.

Evidence 1
The first evidence is to search the protein against the Conserved Domain Database
(CDD) by using rps-blast. The structure of this evidence can be found in Figure 3. For a
protein, its three dimensional structure is made up of smaller functional units called
domains [13,28]. The CDD is a database that contains domains that are evolutionarily
important to different organisms that are considered correct [13]. The CDD is manually
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curated, so it does not have the same failings as databases like GenBank. When a protein
has a domain found within the CDD, this is an indication that this protein is correct, so it
passes this evidence. When there are no hits for a protein, this is an indication that the
protein is incorrectly annotated. The structure of this evidence can be found in Figure 5.

Protein i

RPS-BLAST against CDD

Was there a hit?
Yes

No

Pass

Fail
Figure 5: Structure of Evidence 1

Evidence 2
The second evidence analyzes the protein’s corresponding genomic sequence. A
correct protein should have conserved domains within its current frame. If a protein in a
different frame contains a conserved domain, this indicates that the alternate frame is
most likely the correct frame, meaning that the current annotation is incorrect. For this
evidence each of the protein's nucleotides are translated in six different frameshifts being
0, 1, 2, -0, -1, and -2. An example each of the six possible frameshifts, with the codons in
alternating colors, can be seen in Table 1. To avoid missing pieces of the alternate frames’
proteins, the flanking intergenic genomic sequences are added to the protein’s
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corresponding genomic sequence. If there is a domain found within any of the
frameshifts, this is counted as failing the evidence. If there are no domains found within
the frameshifts, then this protein passes the evidence. The structure of this evidence can
be seen in Figure 6.

Protein i

6-frame translation

RPS-BLAST against CDD

Are there any hits?
No

Yes

Pass

Fail
Figure 6: Structure of Evidence 2

Evidence 3
The third evidence examines the synteny of protein, which provides the relative
position of the protein in the organism genome and it expected to be conserved among
similar organisms [29]. To evaluate the synteny, the strandedness and the order of protein
will be evaluated. To determine if a protein exhibits similar synteny with its flanking
protein sequences against a homologous protein with similar flanking sequences, each of
the flanking sequences of the protein in question will be used in a BLAST search against
a BLAST database made of proteins from the same genus as the proteins being tested.
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For each hit from the protein on the 5' end of the protein being tested, it is matched up
with each other protein hit from the protein on the 3' end. If any of these combinations of
two proteins are flanking one protein, this protein's synteny is conserved and it passes this
evidence. If it had failed, then the protein fails the evidence. The structure of this
evidence can be found in Figure 7.

Protein i

5' protein p

Proteins homologous to p

3' protein q

Proteins homologous to q

Do any pairing of proteins of these two sets flank a single protein?
No

Yes

Pass

Fail

Figure 7 : Structure of Evidence 3
Evidence 4
The fourth evidence views the codon bias of the protein. Recall that a codon is a
set of three sequential bases from the previous section. Since there are four total bases
and three bases comprise a codon, it is easy to see that there are 64 possible codons.
However, there are only 21 amino acids for which can be coded for. This means that there
are multiple codons which code for the same amino acid or stop codon. There are 22
different amino acids that can be produced from a given codon, which means each amino
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acid or stop codon has an average of 3 ways that it can be coded. This means a protein of
100 amino acids could be coded by about 5 x 1047 different nucleotide sequences [30].
However, not all these codons will be evenly used to code for the same protein, as
discussed before with codon bias. This is an evolutionary response to different forces
such as GC content or limiting metabolic load due to tRNA synthesis [30,31]. By having
a codon bias, an organism can produce more of the same tRNA to code for the same
amino acid, resulting in less energy needed to differentiate tRNA molecule. Between
similar organisms, a similar codon bias is exhibited [30]. To show this similarity, an
algorithm will be developed that clusters like proteins based on codon bias into a binary
tree. The evidence 4 will be collected based on whether the protein will cluster with
organism from the same genus. If a protein is clustered with its genus, then it passes the
evidence, otherwise it will be considered to fail this evidence. The structure of this
evidence can be found in Figure 8.

Protein i

Compute Bias

Is this bias closest to another organism in the same family?
No

Yes
Pass

Fail
Figure 8: Structure of Evidence 4
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Evidence 5
The fifth evidence analyzes the isoelectric point of the protein in comparison to
the expected normal confines of isoelectric point. This is found by using the HendersonHasselbach equation [32]. To determine the isoelectric point of the protein an algorithm
as described by Tabb having O(log(n)) time [32] will be implemented. Since most all
proteins are expected to have and isoelectric point between 4 and 10, protein showing the
isoelectric point outside of the range is expected to be wrongly annotated [33].

Evidence 6
The final evidence analyzes the isoelectric point of the protein in comparison to
other proteins from organisms of the same genus. Within a cell, proteins that have a
similar location and function will have a similar isoelectric point [33]. By using a BLAST
search, a set of homologous proteins are found within the genus. If any of those proteins
matches the isoelectric point of the protein within a certain degree of error, then this
protein passes the evidence, otherwise, the protein fails the evidence. The structure of
this evidence can be found in Figure 9.
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Protein i

Find homologous proteins (BLASTP)

Do homologous proteins exhibit a similar isoelectric
point?
No

Yes
Pass

Fail
Figure 9: Structure of Evidence 6

Weighting
Finally, the overall score for any annotation will be decided based on a weighting
system. The purpose of the weighting system is to give more emphasis to evidence that
apply more strongly to a families. For instance, a family may have an abnormally high
isoelectric point average, but most all of the proteins within that family have domains that
are recorded within the CDD. In this case, the weight applied to Evidence 1 would be
weighted more heavily, by receiving a larger multiplier and Evidence 5 would be
weighted less heavily, by receiving a smaller multiplier. To do this, each of the protein
descriptions are checked to find a set of proteins that are known to be correctly annotated,
known as the positive control. If a protein has been given an Enzyme Commission
number, this protein is considered correctly annotated and used within the positive
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control. The set of proteins belonging to the positive control are determined in the
database population step. For each genus, the frequencies of all passing evidence tests
are summed together. To give the weight for each evidence test, the frequency of the
number of proteins from the positive control passing evidence test is divided by the sum
of all the frequencies for all evidences. This weight shows the importance of a given
evidence property within a given genus. The equation for determining the evidence
weights for a family can be found in Equation 1.

W i=

Pc i
n

∑ Pci
i=1

Equation 1a

n

S=∑ W i bi

i =1
Equation 1b

Pci – Positive control protein i
Wi – Weight for evidence test i
bi – Binary coefficient for evidence i

Scoring
To determine the score of an individual protein, the respective weight is
multiplied by a coefficient based on whether the protein passed or failed the given
evidence. The coefficient will be 0 if the protein failed and 1 if the protein passed.
Finally, all of these products will be summed together to determine the protein's score.
From this, one can determine how closely this protein is to being correctly annotated. By
giving a score as opposed to a binary number, this can show which sequences need to be
re-annotated there by increasing the reliability of sequence annotation. The equation for
determining the score can be found in Equation 2.
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Statistical Analysis
To examine each of the evidence tests and the data as a whole, a series of
statistical tests were performed to determine the data’s statistical significance. For each
evidence test, a Chi-squared test [40] was performed, comparing the proportion of the
proteins in the positive control passing the evidence test to the proportion of proteins not
included in the positive control passing the evidence test. The Chi-squared test compares
an expected value to the observed value. This test was chosen to examine the difference
between the positive control set and the case study set. Proportional values were used
rather than the true frequencies, so that the large numbers did not skew the Chi-squared
tests. This Chi-squared test is to measure the representation of passed evidence tests in
the positive control sample versus the representation in the case study sample. For each
set, the proportion of the positive control proteins passing the evidence (13356 samples
tested) is compared against the proportion of the case study proteins passing the evidence
test. If the Chi-squared test shows a statistical significance between the positive control
sample and the case study sample, this means that the quality examined within the
evidence test is important for the validity of the protein. If the Chi-squared test is shown
to be not statistically significant, then we must conclude that there is no significant
difference in the pass rate for that particular evidence test between the positive control
and the case study, showing that this evidence is a weak identifier for protein validity.
In addition to the Chi-squared test, a two-sampled, two tailed Z-test [41] was used
to compare the distributions of scores. This test enables the comparison of each set of
protein scores to each other, based upon the standard deviations. This test was chosen to
compare the ranges of scores of the positive control and the case study sets. Rather than
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only comparing a single facet of the score, this test enables us to see the entire ranges of
scores. If the Z-test shows a statistical significance between the two sets of scores, and
the z-value is positive, this shows that there is a clear difference between the positive
control samples and case study samples, meaning that there is an increased level of
correct proteins in the case study samples compared to the positive control samples. If
the Z-test shows a statistical significance between the two sets of scores, and the z-value
is negative, this shows that there is a clear difference between the positive control
samples and case study samples, meaning that there is a decreased level of correct
proteins in the case study samples compared to the positive control samples. If the Z-test
shows no statistical significance between the two sets of scores, and the z-value is
negative, this shows that there is no clear difference between the positive control samples
and case study samples.

RESULTS AND DISCUSSION
WRAPS was used to analyze 88,023 proteins belonging to the Yersinia,
Staphylococcus, and Bacillus genera available on University of Nebraska at Omaha's
KLAB server, which partially serves as a database for all bacterial genomes found in
January 2011 version of GenBank. For this set, 13356 proteins have been manually
annotated, both structurally and functionally. In Appendix A, a table of the results of
each possible outcome from the evidence tests can be found. For this set, the positive
control set was used as a template for which to predict the whole set. From this, the
amount in each category was expected to grow in proportion equal to the magnitude of
the increase in size of the test set. We would expect this because of the protein homology
that exists within closely related prokaryotes. In the prokaryotes used in the study, such
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as Yersinia pestis, these organisms have many proteins existing within the positive
control. In closely related organisms, we would expect that homologous proteins would
be found within the genomes. These homologous proteins would be expected to exhibit
the same properties as their cousins within the positive control. However, viewing the
difference in sizes between the expected column and the observed column, it is clear that
the data set is not as correctly annotated as the positive control set.
To help with the understanding of this data, I submit two terms. The first term to
be defined is evidence class. This is row in the table, representing a single possible
outcome on all of the evidence tests, which can be expressed by a bit string. For
instance, score class could be passing the first evidence test, passing the second evidence
test, failing the third evidence test, passing the fourth evidence test, passing the fifth
evidence test and failing the sixth evidence test, which would result in a bit string of
110110. In total, there are 64 possible evidence classes, as there are two discrete possible
outcomes of each evidence test. The second term to be used within the context of this
data is annotational correctness. This is represented by the score given. A higher score
shows that an evidence class shows a higher annotational correctness. It should also be
noted that the table is ordered by the evidence classes, not the annotational correctness. It
is important to note that proteins within the positive control may belong to evidence
classes which have a lower level of annotational correctness than others. In the case of
the positive control, this is the data in which the weighting system is trained. Even
amongst correctly annotated proteins there will be variance. However, the variance
between annotational evidence classes in the whole data set will vary much more, as we
would image that proteins are missanotated within the set.
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In this data set, it should be noted that the proportions that the different evidence
class are zero-sum, meaning, for every decrease in a single evidence class's proportion,
one or more other evidence classes must increase in proportion within the data set. In
the system presented, the addition of unverified proteins drops the frequency of evidence
classes corresponding to more correct annotations, with an increase in the frequency of
evidence classes corresponding to less correct annotations. To introduce a change in
evidence class frequency, this would be caused by the additional passing or failing from
the evidences. For each of the evidence class frequencies that decrease in comparison to
the positive control, this is due to the failure of more evidence tests, as noted by the
general decrease in the annotational correctness of the entire data set when compared to
the positive control. For the frequency of a higher annotational correctness evidence
class to drop and the frequency of a similar evidence class of lesser annotational
correctness, it is more probable that a single test was failed rather than the multiple tests.
When examining evidence classes, such as 111111 and 1111110, it can be seen that there
is a decrease in proportion of proteins at this evidence class when compared to the
positive control. It should be noted that when comparing these two bit strings to 111101
and 111100 respectively, the evidence classes that are different from the first two
evidence classes by failing evidence 5. This can also be observed for many of the other
evidence classes exhibiting a high annotational correctness. For the evidence tests
needed to fail to change the frequencies of evidence classes, evidence 1 and 5 were failed
the most. This mirrors the weights assigned to the individual evidences, as the weights
assigned to evidence 1 and 5 are the highest of all evidences. This shows that these
properties tested by the evidence 1 and 5 give a protein a higher degree of annotational
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correctness than other properties, and are properties exhibited in correctly annotated
proteins. Table 2, which is a table of the weights calculated along with the sensitivity and
the number of proteins from each of the evidence test passing from both the full data set
and the positive control. For the tests, it was not possible to calculate the specificity of
the tests, as there are no known negatives without testing in a laboratory, since known
wrongly annotated proteins would not be knowingly inserted into GenBank. In a side
experiment, randomly generated DNA sequences were used to synthesize proteins to be
tested. However, in each of the 1000 sequences generated, each failed every evidence
test but evidence 2.

Table 2: Weights, and sensitivity of positive control data

ev1
ev2
ev3
ev4
ev5
ev6

Bacillus
Staphylococcus
Yersinia
Positive Control
Sensitivity
0.301
0.295
0.246
13332
0.998203
0.071
0.055
0.046
2563
0.191899
0.036
0.013
0.102
3775
0.282645
0.142
0.259
0.202
10784
0.807427
0.299
0.288
0.240
13017
0.974618
0.150
0.088
0.162
7208
0.539683

Based on the evidence presented, the most important properties that were known
domains as shown by evidence 1, having an isoelectric that fits a typical range as shown
by evidence 5, and by having a codon bias that is also expressed by another member of
the same genus. In the case of evidence 1, it was quite obvious how important having a
well-known domain, as in the evidence class table, as there are hardly any proteins that
did not contain a domain not known to the CDD. In the case of evidence 5, it was not
nearly as pronounced as evidence 1, but when viewing the evidence class table, there is a
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significant drop in the frequency of evidence class members in the positive control
whenever evidence 5 is failed when compared to the evidence classes that did pass
evidence 5. While this test is a good indication of a protein’s annotation’s correctness, I
believe that it could be refined so that it more reflects the individual organisms, as
providing just a flat range of isoelectric may incorrectly fail the proteins from more
extremophilic prokaryotes. In the case of evidence 4, it is shown much in the same way
as evidence 5, but not nearly as pronounced. This evidence can also be improved with
adding more flexibility to the bias model, by allowing one or two mismatches between
the protein's bias bit string and matching bit strings. As a tradeoff, a certain number of
matching strings would need to be able to be matched for the protein to pass this evidence
test.
Despite the successes with evidence tests 1, 4, and, 5, evidence tests 2, 3, and 6
admittedly need more work. To begin, evidence test 3 is probably the hardest test of all
of the evidence tests to be able to prove without, as to increase its lenience, would greatly
increase its complexity. One such way would be to allow small numbers of proteins
within the proteins exhibiting synteny. In the case of evidence 6, this evidence test
suffers from the unproven functional annotations. To improve this, rather than finding a
homologous protein from all of the proteins within the database, only homologous
proteins from the positive control should be used. This would ensure that homologous
proteins that are found truly have a homologous function. The final sub-par evidence as
shown by the execution of the system is evidence 2. Unlike its sister evidence, evidence
1, it is a negative evidence, so rather than looking for the presence of the domains, it is
looking for the absence in the alternate frames. To improve this evidence, the genomic
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location of domains can be noted and queried against the database. In the case that
proteins would overlap, this could be checked so that finding true protein within another
true protein would not constitute a failure.
Table 3: Chi-Squared test on each evidence test against the positive control
Evidence Test
1
2
3
4
5
6

Positive Control vs All
Proteins
P = 4.90e-5
P = 0.83
P = 0.92
P = 0.88
P = 0.49
P = 0.84

Positive Control vs Case
study
P = 1.71e-6
P = 0.80
P = 0.90
P = 0.85
P = 0.41
P = 0.81

Examining the Chi-squared tests (Table 3), the difference in correctness in the
positive control samples and the case study samples was shown to be statistically
significant in evidence test 1. In the other evidence tests, the difference positive control
proteins and the case study proteins was shown to be not statistically significant. The
results from these Chi-squared tests, show us that there is a significant difference only in
the conserved domains located in the positive control proteins and the case study proteins
suggesting that the case study samples are enriched with incorrect annotations. Since we
are almost certain that the case study set contains incorrectly annotated proteins, we must
conclude that this is the reason for the decreased proportion in the proteins passing this
evidence. This confirms to us that having a domain that is known to be correct is a
defining feature within correctly annotated proteins.
In the other evidence tests, this shows that there is no significant difference
between the case study proteins and the positive control proteins. While these results
may seem to show that evidence tests 2, 3, 4, 5, and 6 do not matter between sets of
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correctly annotated and incorrectly annotated proteins, it is important to note that we do
know the true annotations of the case study proteins. It is extremely likely that many of
these proteins are correctly annotated. If we use any evidence test on any two sets of
correctly annotated proteins, we would expect that there should be no statistically
significant difference between the result of either evidence tests. In the sample sets used,
the ratio of incorrectly annotated proteins to total sample set can easily change the
statistical significance of the evidence tests. In addition to the makeup of the case study
set, the statistical insignificance of the case study set may also be due to the tuning of the
individual evidence tests. For instance, a minority of both the positive control and the
case study passed evidence test 3. This lack of passed tests is also reflected within the
sensitivity shown in Table 2. This suggests that this evidence test is too stringent. To
correct this, it could be changed to allow a number of other genes within the genes
exhibiting synteny (within a threshold), as long as the three proteins exhibiting synteny
maintain their order.

Table 4: Z-test of protein scores

z-value
Case study vs Positive
Control
All proteins vs Positive
Control

P-value
-81.99003069 P≈0
-41.98363913 P≈0

Examining the results of the Z-test (Table 4), shows that the difference between
the case study proteins and the positive control is statistically significant. A histogram
showing the amount of proteins relative each of the 64 possible scores can be seen below
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in Figure 10. In this histogram, it is plain to see that there is a reduction in the scores
when comparing the case study set to the positive control set. This reduction in scores
and a statistically significant difference suggest that there are wrongly annotated proteins
within the case study data set. When adding this to the analysis done with the Chisquared test, this suggests that while only one evidence test was statistically significant,
the aggregation of all of the evidence tests show that there is a larger difference between
the positive control data set and the case study data set.

Figure 10: Histogram of scores from positive control and case study proteins

In pipelines currently being used in sequencing today, the data generated from
WRAPS would greatly improve the quality of the annotated sequences that are released.
`

38
While I do not believe WRAPS will be adopted by many, if any pipelines, the tests
adapted within it can be used within current protein annotation pipelines. By using an
automated method that quickly and efficiently identifies possible missanotated proteins to
pipelines, this brings a dramatic increase in speed compared to traditional wet-lab protein
annotation, and more accuracy to the current methods of automated annotation.
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APPENDIX A
ev1 ev2 ev3 ev4 ev5 ev6 Yersinia Staphylococcus Bacillus Avg. Score Pos. Control Expect Observed Obs. Growth/Expect
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0.92
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0.65

684 4508

2922

0.65

1

0

0

1

0

0

0.44
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1

0
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0.59
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0.64
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0.11
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0.71
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0.93
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APPENDIX B
Setting
Configurations

WRAPS Settings

WRAPconfiguration.pl

WRAPS.config

User credentials

Creating Database
tables

WRAPcreate.pl

Adds tables

MySQL DB

`
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User credentials

Start Protein
MySQL DB

WRAPlauncher.pl
Protein id
WRAPS_start.pl

wraps.sql
WRAPS_start.pl
Pass/fail
Pass/fail

ev1.pl

Pass/fail

ev2.pl

...

evn.pl

Evaluation of properties

MySQL DB

`
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MySQL DB

Evidence 1

`

Get Protein
ev1.pl

.faa file
rpsblast

CDD

Result.xml

Evidence 2
Get Protein

MySQL DB

ev2.pl
6 frame translation

.faa file

rpsblast

CDD

Result.xml

`
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Evidence 3

MySQL DB
Get Proteins
ev3.pl

Protein 1 fasta
Protein 2 fasta

blastp
Results 1
Results 2

Genus
BlastDB
Find proteins that
have p_ids differing by 2

Evidence 4
MySQL DB

Find synonymous codon
usage (same bit string)

ev4.pl

`
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Evidence 5

MySQL DB
Get Protein
ev5.pl

Test isoelectric
range

Evidence 6

MySQL DB
Get Protein
ev6.pl

Genus
BlastDB

blastp

Results

Homologous
proteins

Compare isoelectric point

`
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APPENDIX C

Legend
genome.g_id – Identification number assigned to an individual GenBank file by the
genome.database
genome.gacc – Genomic accession number from GenBank
genome.genus – Genus of the organism
genome.path – path to GenBank file
genome.ts – timestamp
protein.p_id - Identification number assigned to an individual protein
protein.g_id – foreign key referencing genome.g_id, corresponds to the genome in which
the protein belongs
protein.pacc – protein accession number
protein.p_desc – description of the protein
protein.start – nucleotide start position of the protein
protein.end – nucleotide end position of the protein
protein.strand_id – number assigned to sequential proteins on the same strand. 3’ to 5’
`
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strand is negative while the 5’ to 3’ strand is positive
protein.pseq – protein sequence
genweight.genus – genus for weighs
genweight.wn – weight for evidence test n
positive.p_id – protein id for positive control protein
bias.p_id – protein id for protein
bias.bit_string – bit string representing preferred codon usage
bias.bit_num – number of codons in which the protein holds a bias for
hom.p_id – protein id for protein
hom.hom_id – protein id for homologous protein
trans.p_id – protein id for protein
trans.nseq – nucleotide sequence for protein
intergenic.p_id – protein id for protein
intergenic.p_id5 – 5’ neighboring protein (if any)
intergenic.p_id3 – 3’ neighboring protein (if any)
intergenic.inter5 – 5’ intergenic sequence
intergenic.inter3 – 3’ intergenic sequence
evn.p_id – protein id for protein
evn.pass – Boolean variable representing protein passing (1) or failing (0) evidence n

`
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Appendix D
LOCUS
DEFINITION

SCU49845
5028 bp
DNA
PLN
21-JUN-1999
Saccharomyces cerevisiae TCP1-beta gene, partial cds, and Axl2p
(AXL2) and Rev7p (REV7) genes, complete cds.
ACCESSION
U49845
VERSION
U49845.1 GI:1293613
KEYWORDS
.
SOURCE
Saccharomyces cerevisiae (baker's yeast)
ORGANISM Saccharomyces cerevisiae
Eukaryota; Fungi; Ascomycota; Saccharomycotina; Saccharomycetes;
Saccharomycetales; Saccharomycetaceae; Saccharomyces.
REFERENCE
1 (bases 1 to 5028)
AUTHORS
Torpey,L.E., Gibbs,P.E., Nelson,J. and Lawrence,C.W.
TITLE
Cloning and sequence of REV7, a gene whose function is required for
DNA damage-induced mutagenesis in Saccharomyces cerevisiae
JOURNAL
Yeast 10 (11), 1503-1509 (1994)
PUBMED
7871890
REFERENCE
2 (bases 1 to 5028)
AUTHORS
Roemer,T., Madden,K., Chang,J. and Snyder,M.
TITLE
Selection of axial growth sites in yeast requires Axl2p, a novel
plasma membrane glycoprotein
JOURNAL
Genes Dev. 10 (7), 777-793 (1996)
PUBMED
8846915
REFERENCE
3 (bases 1 to 5028)
AUTHORS
Roemer,T.
TITLE
Direct Submission
JOURNAL
Submitted (22-FEB-1996) Terry Roemer, Biology, Yale University, New
Haven, CT, USA
FEATURES
Location/Qualifiers
source
1..5028
/organism="Saccharomyces cerevisiae"
/db_xref="taxon:4932"
/chromosome="IX"
/map="9"
CDS
<1..206
/codon_start=3
/product="TCP1-beta"
/protein_id="AAA98665.1"
/db_xref="GI:1293614"
/translation="SSIYNGISTSGLDLNNGTIADMRQLGIVESYKLKRAVVSSASEA
AEVLLRVDNIIRARPRTANRQHM"
gene
687..3158
/gene="AXL2"
CDS
687..3158
/gene="AXL2"
/note="plasma membrane glycoprotein"
/codon_start=1
/function="required for axial budding pattern of S.
cerevisiae"
/product="Axl2p"
/protein_id="AAA98666.1"
/db_xref="GI:1293615"
/translation="MTQLQISLLLTATISLLHLVVATPYEAYPIGKQYPPVARVNESF
TFQISNDTYKSSVDKTAQITYNCFDLPSWLSFDSSSRTFSGEPSSDLLSDANTTLYFN
VILEGTDSADSTSLNNTYQFVVTNRPSISLSSDFNLLALLKNYGYTNGKNALKLDPNE
VFNVTFDRSMFTNEESIVSYYGRSQLYNAPLPNWLFFDSGELKFTGTAPVINSAIAPE
TSYSFVIIATDIEGFSAVEVEFELVIGAHQLTTSIQNSLIINVTDTGNVSYDLPLNYV
YLDDDPISSDKLGSINLLDAPDWVALDNATISGSVPDELLGKNSNPANFSVSIYDTYG
DVIYFNFEVVSTTDLFAISSLPNINATRGEWFSYYFLPSQFTDYVNTNVSLEFTNSSQ
DHDWVKFQSSNLTLAGEVPKNFDKLSLGLKANQGSQSQELYFNIIGMDSKITHSNHSA
NATSTRSSHHSTSTSSYTSSTYTAKISSTSAAATSSAPAALPAANKTSSHNKKAVAIA
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CGVAIPLGVILVALICFLIFWRRRRENPDDENLPHAISGPDLNNPANKPNQENATPLN
NPFDDDASSYDDTSIARRLAALNTLKLDNHSATESDISSVDEKRDSLSGMNTYNDQFQ
SQSKEELLAKPPVQPPESPFFDPQNRSSSVYMDSEPAVNKSWRYTGNLSPVSDIVRDS
YGSQKTVDTEKLFDLEAPEKEKRTSRDVTMSSLDPWNSNISPSPVRKSVTPSPYNVTK
HRNRHLQNIQDSQSGKNGITPTTMSTSSSDDFVPVKDGENFCWVHSMEPDRRPSKKRL
VDFSNKSNVNVGQVKDIHGRIPEML"
complement(3300..4037)
/gene="REV7"
complement(3300..4037)
/gene="REV7"
/codon_start=1
/product="Rev7p"
/protein_id="AAA98667.1"
/db_xref="GI:1293616"
/translation="MNRWVEKWLRVYLKCYINLILFYRNVYPPQSFDYTTYQSFNLPQ
FVPINRHPALIDYIEELILDVLSKLTHVYRFSICIINKKNDLCIEKYVLDFSELQHVD
KDDQIITETEVFDEFRSSLNSLIMHLEKLPKVNDDTITFEAVINAIELELGHKLDRNR
RVDSLEEKAEIERDSNWVKCQEDENLPDNNGFQPPKIKLTSLVGSDVGPLIIHQFSEK
LISGDDKILNGVYSQYEEGESIFGSLF"

gene
CDS

ORIGIN
1
61
121
181
241
301
361
421
481
541
601
661
721
781
841
901
961
1021
1081
1141
1201
1261
1321
1381
1441
1501
1561
1621
1681
1741
1801
1861
1921
1981
2041
2101
2161
2221
2281
2341
2401
2461
2521

gatcctccat
ccgacatgag
ctgcatctga
gaaccgccaa
ccacactgtc
agacgcgaaa
attttggcaa
aatacccatc
gagtcgccct
tttactctca
acaattactt
cgtatatcaa
ctactatatc
aacaataccc
cctataaatc
gctggctttc
tatctgatgc
acagcacgtc
tatcgtcaga
acgctctgaa
ctaacgaaga
ccaattggct
actcggcgat
gattttctgc
ctattcaaaa
ctctaaacta
acttattgga
cagatgaatt
cttatggtga
ttagttctct
cttctcagtt
aagaccatga
agaatttcga
tatattttaa
caacgtccac
acactgcaaa
cagcagccaa
ctatcccatt
gaagggaaaa
atcctgcaaa
atgcttcctc
aattggataa
ctctatcagg

atacaacggt
acagttaggt
agccgctgaa
tagacaacat
attattataa
aaaaaagaac
cttatgtttc
gtaggtatgg
cctttgtcga
catcctgtag
aatagaaaaa
gaagcattca
actactccat
cccagtggca
gtctgtagac
gtttgactct
gaacaccacg
tttgaacaat
tttcaatcta
actagatcct
atccattgtg
gttcttcgat
tgctccagaa
cgttgaggta
tagtttgata
tgtttatctc
tgctccagac
actcggtaag
tgtgatttat
tcccaatatt
tacagactac
ctgggtgaaa
caagctttca
catcattggc
aagaagttct
aatttcttct
taaaacttca
aggcgttatc
tccagacgat
taaaccaaat
gtacgatgat
ccactctgcc
tatgaataca

atctccacct
atcgtcgaga
gttctactaa
atgtaacata
ttagaaacag
aacgcgtcat
ctcttcgagc
ttaaagatag
gtaattttca
tgattgacac
ttatatcttc
cttaccatga
ctagtagtgg
agagtcaatg
aagacagctc
agttctagaa
ttgtatttca
acataccaat
ttggcgttgt
aatgaagtct
tcgtattacg
tctggcgagt
acaagctaca
gaattcgaat
atcaacgtta
gatgacgatc
tgggtggcat
aactccaatc
ttcaacttcg
aacgctacaa
gtgaatacaa
ttccaatcat
ttaggtttga
atggattcaa
caccactcca
acctccgctg
tctcacaata
ctagtagctc
gaaaacttac
caagaaaacg
acttcaatag
actgaatctg
tacaatgatc

caggtttaga
gttacaagct
gggtggataa
tttaggatat
aacgcaaaaa
agaacttttg
agtactcgag
catctccaca
cttttcatat
tgcaacagcc
ctcgaaacga
cacagcttca
ccacgcccta
aatcgtttac
aaataacata
cgttctcagg
atgtaatact
ttgttgttac
taaaaaacta
tcaacgtgac
gacgttctca
tgaagtttac
gttttgtcat
tagtcatcgg
ctgacacagg
ctatttcttc
tagataatgc
ctgccaattt
aagttgtctc
ggggtgaatg
acgtttcatt
ctaatttaac
aagcgaacca
agataactca
cctcaacaag
ctgctacttc
aaaaagcagt
tcatttgctt
cgcatgctat
ctacaccttt
caagaagatt
atatttccag
agttccaatc

tctcaacaac
aaaacgagca
catcatccgt
acctcgaaaa
ttatccacta
gcaattcgcg
ccctgtctca
acctcaaagc
gagaacttat
accatcacta
tttcctgctt
gatttcatta
tgaggcatat
atttcaaatt
caattgcttc
tgaaccttct
cgagggtacg
aaaccgtcca
tggttatact
ttttgaccgt
gttgtataat
tgggacggca
catcgctaca
ggctcaccag
taacgtttca
tgataaattg
taccatttcc
ttctgtgtcc
cacaacggat
gttctcctac
agagtttact
attagctgga
aggttcacaa
ctcaaaccac
ttcttacaca
ttctgctcca
agcaattgcg
cctaatattc
tagtggacct
gaacaacccc
ggctgctttg
cgtggatgaa
ccaaagtaaa

ggaaccattg
gtagtcagct
gcaagaccaa
taataaaccg
tataattcaa
tcacaaataa
agaatgtaat
tccttgccga
tttcttattc
gaagaacaga
ccaacatcta
ttgctgacag
cctatcggaa
tccaatgata
gacttaccga
tctgacttac
gactctgccg
tccatctcgc
aacggcaaaa
tcaatgttca
gcgccgttac
ccggtgataa
gacattgaag
ttaactacct
tatgacttac
ggttctataa
gggtctgtcc
atttatgata
ttgtttgcca
tattttttgc
aattcaagcc
gaagtgccca
tctcaagagc
agtgcgaatg
tcttctactt
gcagcgctgc
tgcggtgttg
tggagacgca
gatttgaata
tttgatgatg
aacactttga
aagagagatt
gaagaattat
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2581
2641
2701
2761
2821
2881
2941
3001
3061
3121
3181
3241
3301
3361
3421
3481
3541
3601
3661
3721
3781
3841
3901
3961
4021
4081
4141
4201
4261
4321
4381
4441
4501
4561
4621
4681
4741
4801
4861
4921
4981

tagcaaaacc
cttctgtgta
tgtcaccagt
aaaaactttt
tgtcttcact
caccatcacc
ctcaaagcgg
ttgttccggt
gaccaagtaa
ttaaggacat
taattttatt
agtttttata
taaaacaaag
attttgtcgt
tcagaaccga
aaattttcat
tccaaactat
ttaataactg
ataatcaaac
tgatcgtctt
aaatcgttct
agaacatcca
acgaactgcg
acatttctat
tctacccatc
tcagtcgtcg
gtttatatta
atattaagaa
ctgtttatgt
tttggtaaag
cttagttcat
ccatctgtca
agcgcgtttg
tccaatgaat
tcttcgcact
atttgctcag
tcactgtctt
gatctcaagt
ttctccactt
ttttcagtgt
tgccatgact

cccagtacag
tatggatagt
ctctgatatt
cgatttagaa
ggacccttgg
atataacgta
taaaaacgga
taaagatggt
gaaaaggtta
tcacggacgc
ttcctgtttt
cttagagaca
atccaaaaat
caccgctgat
ctaaagaagt
cttcttgaca
cgaccctcct
cttcaaatgt
tatttaagga
tatccacatg
ttttattaat
gtataagttc
gcaagttgaa
aaaataaaat
tattcataaa
caaaaacgta
gttaaacagg
agtggaaatt
ttctacgtac
gtgaaagcat
cttttttcca
gcaacatcag
tcgtttgtat
tagcaatttc
tcttttccca
agttcaaatc
ctagctgttg
tattggagtc
cactgtcgag
tagattgctc
cagattctaa

cctccagaga
gaaccagcag
gtcagagaca
gcaccagaga
aacagcaata
acgaagcatc
atcactccca
gaaaattttt
gtagattttt
atcccagaaa
attttttatt
tttaatttta
gctctcgccc
taatttttca
gagttttatt
tttaacccag
gtttctgtcc
tattgtgtca
agatcggaat
ttgtaattca
aatgcagatg
ttctatatag
tgactggtaa
caaattaatg
gctgacgcaa
taccttcttt
gtctagtctt
aaattagtag
ttttgattta
aatgtaaaag
aaaagcaccc
ttgtgtgagc
cttccgtaat
gtccaattct
ttcatctctt
ggcctctttc
ttctagatcc
ttcagccaat
ttgctcgttt
taattctttg
ttttaagcta

gcccgttctt
taaataaatc
gttacggatc
aggaaaaacg
ttagcccttc
gtaaccgcca
caacaatgtc
gctgggtcca
caaataagag
tgctgtgatt
agtggtttac
attccattct
tcttcatatt
ctaaactgat
ttaggaggtt
tttgaatccc
aacttatgtc
tcgttgactt
tcgtcgaaca
ctaaaatcta
gaaaatctgt
tcaattaaag
gtagtgtagt
tagcatttta
cgattactat
ttccgacctt
agtgtgaaag
tgtagacgta
tagcaagggg
ctagaataaa
aatgataata
aataataaaa
tttagtctta
ttttgagctt
tcttcttcca
agtttatcca
tggtttttct
tgctttgtat
ttagcggaca
agctgttctc
ttcaatttct

tgacccacag
ctggcgatat
acaaaaaact
tacgtcaagg
tcccgtaaga
cttacaaaat
aacttcatct
tagcatggaa
taatgtcaat
atacgcaacg
agatacccta
tcaaatttca
gagaatacac
gaataatcaa
gaaaaccatt
tttcaatttc
ctagttccaa
taggtaattt
cttcagtttc
aaacgtattt
aaacgtgcgt
caggatgcct
cgaatgactg
agtataccct
tttttttttc
ttttttagct
ctagtggttt
tatgcatatg
aaaagaaata
atggacgaaa
actaaaatga
tcatcacctc
tcaatgggaa
cttcatattt
aagcaacgat
ttgcttcctt
tggtgtagtt
cagacaattg
aagatttaat
tcagctcctc
ctttgatc

aataggtctt
actggcaacc
gttgatacag
gatgtcacta
aaatcagtaa
attcaagact
tctgacgatt
ccagacagaa
gttggtcaag
atattttgct
tattttattt
tttttgcact
tccattcaaa
aggccccacg
attgtctggt
tgctttttcc
ttcgatcgca
ctccaaatgc
cgtaatgatc
ttcaatgcat
taatttagaa
attaatggga
aggtgggtat
cagccacttc
ttcttggatc
ttctggaaaa
cgattgactg
tatttctcgc
catactattt
taaagagagg
aaaggatttg
cgttgccttt
tcataaattt
gctttggaat
ccttctaccc
cagtttggct
ctcattatta
actctctaac
ctcgttttct
atatttttct

//

`

